Rapid non-invasive tests for diagnostics of infectious diseases

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

A rapid test for an infectious disease that can be used at point-of-care at a physician's office, a pharmacy, or in the field is critical for the prompt and appropriate therapeutic intervention. Ultimately by treating infections early on will decrease transmission of the pathogen. In contrast to metabolic diseases or cancer where multiple biomarkers are required, infectious disease targets (e.g. antigen, antibody, nucleic acid) are simple and specific for the pathogen causing the disease. Our laboratory has focused on three major infectious disease; HIV, Tuberculosis, and Malaria. These diseases are pandemic in much of the world thus putting natives, tourists and military personnel at risk for becoming infected, and upon returning to the U.S., transmitting these diseases to their contacts. Our devices are designed to detect antigens, antibodies or nucleic acids in blood or saliva samples in less than 30 minutes. An overview describing the current status of each of the three diagnostic platforms is presented. These microfluidic point-of-care devices will be relatively inexpensive, disposable, and user friendly.

Original languageEnglish (US)
Title of host publicationSensing Technologies for Global Health, Military Medicine, and Environmental Monitoring IV
PublisherSPIE
Volume9112
ISBN (Print)9781628410495
DOIs
StatePublished - 2014
EventSensing Technologies for Global Health, Military Medicine, and Environmental Monitoring IV - Baltimore, MD, United States
Duration: May 5 2014May 7 2014

Other

OtherSensing Technologies for Global Health, Military Medicine, and Environmental Monitoring IV
CountryUnited States
CityBaltimore, MD
Period5/5/145/7/14

Fingerprint

Infectious Diseases
infectious diseases
Diagnostics
pathogens
nucleic acids
personnel
antigens
antibodies
Antibody
metabolic diseases
military personnel
saliva
tuberculosis
Nucleic acids
Malaria
human immunodeficiency virus
Pathogens
acids
Tuberculosis
Antigens

Keywords

  • HIV
  • Malaria
  • Point-of-care
  • TB

ASJC Scopus subject areas

  • Applied Mathematics
  • Computer Science Applications
  • Electrical and Electronic Engineering
  • Electronic, Optical and Magnetic Materials
  • Condensed Matter Physics

Cite this

Malamud, D. (2014). Rapid non-invasive tests for diagnostics of infectious diseases. In Sensing Technologies for Global Health, Military Medicine, and Environmental Monitoring IV (Vol. 9112). [911203] SPIE. https://doi.org/10.1117/12.2065332

Rapid non-invasive tests for diagnostics of infectious diseases. / Malamud, Daniel.

Sensing Technologies for Global Health, Military Medicine, and Environmental Monitoring IV. Vol. 9112 SPIE, 2014. 911203.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Malamud, D 2014, Rapid non-invasive tests for diagnostics of infectious diseases. in Sensing Technologies for Global Health, Military Medicine, and Environmental Monitoring IV. vol. 9112, 911203, SPIE, Sensing Technologies for Global Health, Military Medicine, and Environmental Monitoring IV, Baltimore, MD, United States, 5/5/14. https://doi.org/10.1117/12.2065332
Malamud D. Rapid non-invasive tests for diagnostics of infectious diseases. In Sensing Technologies for Global Health, Military Medicine, and Environmental Monitoring IV. Vol. 9112. SPIE. 2014. 911203 https://doi.org/10.1117/12.2065332
Malamud, Daniel. / Rapid non-invasive tests for diagnostics of infectious diseases. Sensing Technologies for Global Health, Military Medicine, and Environmental Monitoring IV. Vol. 9112 SPIE, 2014.
@inproceedings{31ffa87a0ef344c3839caa3a0eb1ea16,
title = "Rapid non-invasive tests for diagnostics of infectious diseases",
abstract = "A rapid test for an infectious disease that can be used at point-of-care at a physician's office, a pharmacy, or in the field is critical for the prompt and appropriate therapeutic intervention. Ultimately by treating infections early on will decrease transmission of the pathogen. In contrast to metabolic diseases or cancer where multiple biomarkers are required, infectious disease targets (e.g. antigen, antibody, nucleic acid) are simple and specific for the pathogen causing the disease. Our laboratory has focused on three major infectious disease; HIV, Tuberculosis, and Malaria. These diseases are pandemic in much of the world thus putting natives, tourists and military personnel at risk for becoming infected, and upon returning to the U.S., transmitting these diseases to their contacts. Our devices are designed to detect antigens, antibodies or nucleic acids in blood or saliva samples in less than 30 minutes. An overview describing the current status of each of the three diagnostic platforms is presented. These microfluidic point-of-care devices will be relatively inexpensive, disposable, and user friendly.",
keywords = "HIV, Malaria, Point-of-care, TB",
author = "Daniel Malamud",
year = "2014",
doi = "10.1117/12.2065332",
language = "English (US)",
isbn = "9781628410495",
volume = "9112",
booktitle = "Sensing Technologies for Global Health, Military Medicine, and Environmental Monitoring IV",
publisher = "SPIE",

}

TY - GEN

T1 - Rapid non-invasive tests for diagnostics of infectious diseases

AU - Malamud, Daniel

PY - 2014

Y1 - 2014

N2 - A rapid test for an infectious disease that can be used at point-of-care at a physician's office, a pharmacy, or in the field is critical for the prompt and appropriate therapeutic intervention. Ultimately by treating infections early on will decrease transmission of the pathogen. In contrast to metabolic diseases or cancer where multiple biomarkers are required, infectious disease targets (e.g. antigen, antibody, nucleic acid) are simple and specific for the pathogen causing the disease. Our laboratory has focused on three major infectious disease; HIV, Tuberculosis, and Malaria. These diseases are pandemic in much of the world thus putting natives, tourists and military personnel at risk for becoming infected, and upon returning to the U.S., transmitting these diseases to their contacts. Our devices are designed to detect antigens, antibodies or nucleic acids in blood or saliva samples in less than 30 minutes. An overview describing the current status of each of the three diagnostic platforms is presented. These microfluidic point-of-care devices will be relatively inexpensive, disposable, and user friendly.

AB - A rapid test for an infectious disease that can be used at point-of-care at a physician's office, a pharmacy, or in the field is critical for the prompt and appropriate therapeutic intervention. Ultimately by treating infections early on will decrease transmission of the pathogen. In contrast to metabolic diseases or cancer where multiple biomarkers are required, infectious disease targets (e.g. antigen, antibody, nucleic acid) are simple and specific for the pathogen causing the disease. Our laboratory has focused on three major infectious disease; HIV, Tuberculosis, and Malaria. These diseases are pandemic in much of the world thus putting natives, tourists and military personnel at risk for becoming infected, and upon returning to the U.S., transmitting these diseases to their contacts. Our devices are designed to detect antigens, antibodies or nucleic acids in blood or saliva samples in less than 30 minutes. An overview describing the current status of each of the three diagnostic platforms is presented. These microfluidic point-of-care devices will be relatively inexpensive, disposable, and user friendly.

KW - HIV

KW - Malaria

KW - Point-of-care

KW - TB

UR - http://www.scopus.com/inward/record.url?scp=84907059493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907059493&partnerID=8YFLogxK

U2 - 10.1117/12.2065332

DO - 10.1117/12.2065332

M3 - Conference contribution

SN - 9781628410495

VL - 9112

BT - Sensing Technologies for Global Health, Military Medicine, and Environmental Monitoring IV

PB - SPIE

ER -